Steadfast Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,300
Closed -$7.42M 107
2025
Q4
$7.42M Buy
+45,300
New +$7.1M 0.13% 77

Other funds holding RGEN

Steadfast Capital Management's RGEN Position: Q1 2026 in Review

Steadfast Capital Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 45,300 shares — an estimated $7.42M sold.

Steadfast Capital Management first reported a position in RGEN in Q4 2025 and held it in 1 quarter. The position peaked at $7.42M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Steadfast Capital Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Steadfast Capital Management sold 45,300 Repligen shares in Q1 2026, an estimated $7.42M.
  • Steadfast Capital Management first reported a position in Repligen in Q4 2025 and held it in 1 quarter.
  • Steadfast Capital Management's Repligen position peaked at $7.42M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Steadfast Capital Management's 13F filing for Q1 2026, filed 15 May 2026.